TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Clinical Infectious Diseases
Research on clinical infectious diseases discussed by C. Tamayo and co-researchers
April 1st, 2008
According to a study from the United States, "Although there exists some evidence of the safety and efficacy of probiotics for treatment of disease, many of the clinical trials have lacked methodological quality, particularly with regard to protocol design, selection of population, and product characterization." "Depending on the regulatory route, data need to be collected carefully to satisfy regulatory requirements in the United States and elsewhere. This article discusses how the regulations for probiotics affect clinical research," wrote C. Tamayo and colleagues. The researchers concluded: "It also describes clinical trial design and issues that...
Source: TB & Outbreaks Week (2008-04-01)
|
